Sero-epidemiological studies of pathogen burden: A scoping review
Wellcome Open Research · 11.07.2026 · 11 · 192
DOI: 10.12688/wellcomeopenres.26070.3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Wellcome Open Research, online erschienen am 11.07.2026. Verfasst von Anne Suffel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England, UK. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Open Philantropy, Chinese Academy of Medical Sciences Innovation Fund for Medical Science.
Abstract (Originalsprache)
Background
Methodological advances in serological testing have made it feasible to quantify antibodies to multiple pathogens simultaneously. This has been used to study the impact of pathogen burden, i.e., cumulative lifetime exposure to persistent pathogens, on health and mortality outcomes. However, definitions for pathogen burden using serological data vary considerably. It is unclear how to best combine serological data for multiple pathogens for exposure/outcome definitions in epidemiological studies.
Methods
Following PRISMA-ScR guidelines, we conducted a scoping review of all relevant publications from MEDLINE, Embase, and Scopus until May 1 st , 2025, with no language restrictions. We identified epidemiological studies defining pathogen burden, and which included at least three different pathogens.
Results
We included a total of 74 studies from 19 countries (published 2000–2025). Serology data from 50 different pathogens were analysed across all studies, with pathogen burden measured by combining a range of 3–17 pathogens across studies into a single metric. Approaches included counts of seropositive result, quantiles of antibody titres, and more complex statistical analyses to group pathogens. No study gave a clinical/scientific rationale for the approaches chosen.
Conclusions
Various analytical approaches have been used to define pathogen burden but there was limited justification for the chosen methodological approaches. More integrated approaches are needed for combining scientific and clinical knowledge of the interaction across different pathogens and epidemiological evidence into a meaningful measure of pathogen burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England, UK.
- School of Health and Care Sciences, University of Lincoln, Lincoln, England, UK.
- Centre for Human Genetics, University of Oxford, Oxford, England, UK.
- Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, England, UK.
- Nuffield Department of Population Health, University of Oxford, Oxford, England, UK.
- UK Biobank, Stockport, England, UK.
ORCID-Profile: Anne Suffel, Alexander J Mentzer, Naomi E Allen, Aisha Babi, David Burgner, Charlotte Warren-Gash
Förderung
- Wellcome Trust
- Open Philantropy
- Chinese Academy of Medical Sciences Innovation Fund for Medical Science
Zitieren
APA
Suffel, A., Turton, D., Mansfield, K. E., Mentzer, A. J., Allen, N. E., Babi, A., Burgner, D., Waterboer, T., & Warren-Gash, C. (2026). Sero-epidemiological studies of pathogen burden: A scoping review. Wellcome Open Research, 11, 192. https://doi.org/10.12688/wellcomeopenres.26070.3
Vancouver
Suffel A, Turton D, Mansfield KE, Mentzer AJ, Allen NE, Babi A, et al. Sero-epidemiological studies of pathogen burden: A scoping review. Wellcome Open Research. 2026;11:192. doi:10.12688/wellcomeopenres.26070.3
BibTeX
@article{Suffel2026,
author = {Suffel, Anne and Turton, Danny and Mansfield, Kathryin E and Mentzer, Alexander J and Allen, Naomi E and Babi, Aisha and Burgner, David and Waterboer, Tim and Warren-Gash, Charlotte},
title = {Sero-epidemiological studies of pathogen burden: A scoping review},
journal = {Wellcome Open Research},
year = {2026},
volume = {11},
pages = {192},
doi = {10.12688/wellcomeopenres.26070.3}
}
EUVIMED